INSIGHTS INTO REIMBURSEMENT RATES AND TIMELINES FOR ORPHAN DRUGS IN IRELAND

被引：0
|
作者：
Marsh, S. E. [1 ]
机构：
[1] PharmEkon Ltd, Egham, Surrey, England
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMU107
引用
收藏
页码：S726 / S726
页数：1
相关论文
共 50 条
  • [1] AN ANALYSIS OF THE TIMELINES THROUGHOUT THE REIMBURSEMENT PATHWAY FOR DRUGS IN IRELAND
    Connolly, E.
    Lamrock, F.
    O'Donnell, H.
    Walsh, C.
    Tilson, L.
    Barry, M.
    [J]. VALUE IN HEALTH, 2018, 21 : S191 - S191
  • [2] HTA AND REIMBURSEMENT TIMELINES IN THE REPUBLIC OF IRELAND
    Liu, X.
    [J]. VALUE IN HEALTH, 2022, 25 (12) : S317 - S317
  • [3] AN INVESTIGATION INTO FACTORS INFLUENCING REIMBURSEMENT TIMELINES OF NEW MEDICINES IN IRELAND
    Copeland, C.
    Dooley, B.
    Hernon, M.
    Tracey, M.
    [J]. VALUE IN HEALTH, 2020, 23 : S655 - S655
  • [4] Pricing and reimbursement of orphan drugs in Italy
    Lopatriello, S.
    Schivazappa, C.
    Negrini, C.
    Berto, P.
    [J]. VALUE IN HEALTH, 2006, 9 (06) : A208 - A209
  • [5] REIMBURSEMENT OF ORPHAN DRUGS: WHAT IS THE DIFFERENCE?
    Mueller, E.
    Schmidt, E.
    Ehreth, J.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A311 - A311
  • [6] THE REIMBURSEMENT OF ORPHAN DRUGS ACROSS EUROPE
    Nixon, F.
    [J]. VALUE IN HEALTH, 2008, 11 (06) : A375 - A376
  • [7] PRICING AND REIMBURSEMENT OF ORPHAN DRUGS IN CANADA
    Kumar, J.
    Bachman, E. M.
    [J]. VALUE IN HEALTH, 2011, 14 (03) : A29 - A29
  • [8] REIMBURSEMENT AND PRICING OF ORPHAN DRUGS IN TAIWAN
    Cheng, C. Y.
    Chan, H. W.
    Fang, C. H.
    [J]. VALUE IN HEALTH, 2019, 22 : S856 - S856
  • [9] Pricing and reimbursement of drugs in Ireland
    Barry M.
    Tilson L.
    Ryan M.
    [J]. The European Journal of Health Economics, formerly: HEPAC , 2004, 5 (2): : 190 - 194
  • [10] Authorization and Reimbursement of Orphan Drugs in an International Comparison
    Roll, K.
    Stargardt, T.
    Schreyoegg, J.
    [J]. GESUNDHEITSWESEN, 2011, 73 (8-9) : 504 - 514
12345